Chemclin Diagnostics Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	353.32	436.29	445.34	465.27	470.77	418.2
Revenue Growth (YoY)	-20.40%	-2.03%	-4.28%	-1.17%	12.57%	-8.02%
Cost of Revenue	115.21	113.12	110.56	121.11	119.84	117.25
Gross Profit	238.11	323.17	334.78	344.16	350.94	300.95
Selling, General & Admin	115.47	136.61	133.41	135.17	143.23	129.03
Research & Development	81.34	73.74	65.14	68.36	66.78	54.33
Other Operating Expenses	11.74	5.38	5.03	5.49	3.66	3.22
Operating Expenses	208.3	215.53	203.17	209.05	213.82	186.87
Operating Income	29.81	107.65	131.61	135.11	137.12	114.09
Interest Expense	-7.12	-5.24	-0.47	-0.52	-0.73	-0.01
Interest & Investment Income	18.8	19.79	22.04	25.03	18.29	13.86
Currency Exchange Gain (Loss)	0.07	0.07	0.08	0.4	-0.13	-0.29
Other Non Operating Income (Expenses)	0.25	-0.09	-0.15	-0.08	-0.42	-0.08
EBT Excluding Unusual Items	41.81	122.18	153.12	159.93	154.13	127.57
Gain (Loss) on Sale of Assets	-0.32	0.06	0.14	-0.62	-0.64	-0.34
Asset Writedown	-4.69	-3.67	-2.8	-1.46	-0.32	-
Other Unusual Items	19.35	19.35	15.66	19.51	9.02	8.21
Pretax Income	56.16	137.92	166.12	177.37	162.19	135.44
Income Tax Expense	-0.33	10.84	18.75	24.74	19.43	18.42
Net Income	56.49	127.07	147.37	152.63	142.76	117.02
Net Income to Common	56.49	127.07	147.37	152.63	142.76	117.02
Net Income Growth	-59.45%	-13.77%	-3.44%	6.91%	21.99%	-16.77%
Shares Outstanding (Basic)	408	397	398	402	386	355
Shares Outstanding (Diluted)	408	397	398	402	386	355
Shares Change (YoY)	2.59%	-0.30%	-0.83%	4.10%	8.80%	76.55%
EPS (Basic)	0.14	0.32	0.37	0.38	0.37	0.33
EPS (Diluted)	0.14	0.32	0.37	0.38	0.37	0.33
EPS Growth	-60.47%	-13.51%	-2.63%	2.70%	12.12%	-52.86%
Free Cash Flow	33.68	60.46	-128.32	119.28	116.31	68.65
Free Cash Flow Per Share	0.08	0.15	-0.32	0.30	0.30	0.19
Dividend Per Share	0.125	0.125	0.125	0.347	0.170	-
Dividend Growth	-	-	-63.98%	104.12%	-	-
Gross Margin	67.39%	74.07%	75.17%	73.97%	74.54%	71.96%
Operating Margin	8.44%	24.67%	29.55%	29.04%	29.13%	27.28%
Profit Margin	15.99%	29.13%	33.09%	32.80%	30.32%	27.98%
Free Cash Flow Margin	9.53%	13.86%	-28.81%	25.64%	24.71%	16.41%
EBITDA	82.54	153.7	168.77	175.19	179.97	156.35
EBITDA Margin	23.36%	35.23%	37.90%	37.65%	38.23%	37.39%
D&A For EBITDA	52.73	46.05	37.16	40.08	42.84	42.26
EBIT	29.81	107.65	131.61	135.11	137.12	114.09
EBIT Margin	8.44%	24.67%	29.55%	29.04%	29.13%	27.28%
Effective Tax Rate	-	7.86%	11.29%	13.95%	11.98%	13.60%
Revenue as Reported	353.32	436.29	445.34	465.27	470.77	418.2
Advertising Expenses	-	4.06	6.63	4.1	6.76	5.87

Source: S&P Global Market Intelligence. Standard template. Financial Sources.